|
[Related PubMed/MEDLINE]
Total Number of Papers: 121
|
|
|
|
|
[Display Entries]
|
|
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: CDLQI |
| Long Form |
: Children's Dermatology Life Quality Index |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2020 |
Assessing child quality of life impairments following pediatric burn injuries: Rasch analysis of the children's dermatology life quality index. |
QOL |
| 2 |
2020 |
Association Between Quality of Life and Improvement in Psoriasis Severity and Extent in Pediatric Patients. |
BSA, PASI, QOL |
| 3 |
2020 |
Depressive symptoms among mothers of children with psoriasis-A case-control study. |
BDI, DLQI, PASI, QOL |
| 4 |
2020 |
Factors associated with improvement of quality of life among parents of children with atopic dermatitis: 1-year prospective cohort study. |
AD, DFI, IDQOL, SCORAD |
| 5 |
2020 |
Impact of atopic dermatitis on the quality of life of children and their families. |
AD, DFI, QOL, TIS |
| 6 |
2020 |
Increased attention deficit/hyperactivity and oppositional defiance symptoms of 6-12 years old Chinese children with atopic dermatitis. |
AD, ADHD, ODD, SCORAD |
| 7 |
2020 |
Itch in Children with Type 1 Diabetes: A Cross-Sectional Study. |
4IIQ, NRS, T1D |
| 8 |
2020 |
Quality of Life in Patients with Morphea: A Cross-Sectional Study and a Review of the Current Literature. |
DLQI |
| 9 |
2020 |
Tofacitinib in Pediatric Psoriasis: An Open-Label Trial to Study Its Safety and Efficacy in Children. |
AEs, PASI, PGA |
| 10 |
2020 |
Ustekinumab for the treatment of moderate-to-severe plaque psoriasis in paediatric patients (≥ 6 to < 12 years of age): efficacy, safety, pharmacokinetic and biomarker results from the open-label CADMUS Jr study. |
--- |
| 11 |
2019 |
Direct and Indirect Effects of Crisaborole Ointment on Quality of Life in Patients with Atopic Dermatitis: A Mediation Analysis. |
DLQI, QOL |
| 12 |
2019 |
Does age influence the quality of life in children with atopic dermatitis? |
AD, CCM, IDQOL, QOL, TIS |
| 13 |
2019 |
Examining the association between pruritus and quality of life in patients with atopic dermatitis treated with crisaborole. |
AD, DFI, DLQI, QOL, SPS |
| 14 |
2019 |
Omalizumab as an adjuvant therapy for treating severe atopic dermatitis in children. A serie of cases. |
AD |
| 15 |
2019 |
Pediatric patients with psoriasis and psychiatric disorders: premorbidity and comorbidity in a case-control study. |
CDI, SCARED |
| 16 |
2019 |
Responder Threshold for Patient-Oriented Eczema Measure (POEM) and Children's Dermatology Life Quality Index (CDLQI) in Adolescents with Atopic Dermatitis. |
AD, HRQoL, IGA, PGAD, PGAT, POEM |
| 17 |
2019 |
Severity of disease and quality of life in parents of children with alopecia areata, totalis, and universalis: A prospective, cross-sectional study. |
FDLQI, QLCCDQ, QOL, SALT |
| 18 |
2019 |
Skin-related quality of life in children and adolescents with congenital melanocytic naevi - an analysis of self- and parent reports. |
CMN, QOL |
| 19 |
2019 |
[Severity scores for childhood psoriasis: A systematic literature review]. |
BSA, PASI, PGA |
| 20 |
2018 |
A Randomized Controlled Trial of an Eczema Care Plan. |
CI, ECP, IDQOL, POEM, QOL |
| 21 |
2018 |
Crisaborole Ointment Improves Quality of Life of Patients with Mild to Moderate Atopic Dermatitis and Their Families. |
AD, DFI, DLQI, QOL |
| 22 |
2018 |
Effect of atopic dermatitis on quality of life and its psychosocial impact in Asian adolescents. |
AD, EASI, QOL |
| 23 |
2018 |
Impact of Palmoplantar Dermatoses on Quality of Life. |
DLQI, HE, PPK, PPP, QOL |
| 24 |
2018 |
Impact of psoriasis in the quality of life of children, adolescents and their families: a cross-sectional study. |
CDI, FDLQI, STAIC |
| 25 |
2018 |
Patient-Reported Outcome Measures for Pediatric Psoriasis: A Systematic Review and Critical Appraisal from International Dermatology Outcome Measures (IDEOM). |
COSMIN, IDEOM, PROMs, SPI |
| 26 |
2017 |
|
AD, ATSW, DLQI, INF, SCORAD |
| 27 |
2017 |
Atopic dermatitis characteristics and medication-use patterns in school-age children with AD and asthma symptoms. |
AD, QOL, SA-EASI, TCS |
| 28 |
2017 |
Clinical Signs, Staphylococcus and Atopic Eczema-Related Seromarkers. |
AD, anti-SE, APC, SCORAD, TEWL, Th, Treg |
| 29 |
2017 |
IMPACT OF ATOPIC DERMATITIS ON THE QUALITY OF LIFE OF PEDIATRIC PATIENTS AND THEIR GUARDIANS. |
DFI, PPMCC, SCORAD |
| 30 |
2017 |
Methotrexate for Severe Childhood Atopic Dermatitis: Clinical Experience in a Tertiary Center. |
AD, IGA |
| 31 |
2017 |
Objective measurement of two clinical signs in childhood atopic eczema in research and therapeutics. |
AD, NESS |
| 32 |
2017 |
Phytotherapeutic potential of natural herbal medicines for the treatment of mild-to-severe atopic dermatitis: A review of human clinical studies. |
AD, DLQI, SCORAD, TEWL |
| 33 |
2017 |
Relevance of Cat and Dog Sensitization by Skin Prick Testing in Childhood Eczema and Asthma. |
AE, aOR, CI, SPT |
| 34 |
2017 |
Validation of the Simplified Psoriasis Index in Dutch children and adolescents with plaque psoriasis. |
PASI, SPI, SPI-s |
| 35 |
2017 |
[Evaluation of quality of life of children with atopic dermatitis before and after treatment]. |
AD, DFI, IDQOL, SCORAD |
| 36 |
2016 |
Comparison of the Dermatology Life Quality Index and the Children's Dermatology Life Quality Index in assessment of quality of life in patients with psoriasis aged 16-17 years. |
DLQI, QOL |
| 37 |
2016 |
Correlation between Severity of Atopic Dermatitis and Sleep Quality in Children and Adults. |
AD, CSHQ, DLQI, PSQI, QOL, SCORAD |
| 38 |
2016 |
Eczema Trials: Quality of Life Instruments Used and Their Relation to Patient-reported Outcomes. A Systematic Review. |
DFI, DLQI, GREAT, IDQOL |
| 39 |
2016 |
Efficacy of sodium hypochlorite (bleach) baths to reduce Staphylococcus aureus colonization in childhood onset moderate-to-severe eczema: A randomized, placebo-controlled cross-over trial. |
AD, ITT, S. aureus, SCORAD, SH, TEWL |
| 40 |
2016 |
Impact of Cosmetic Camouflage on the Quality of Life of Children With Skin Disease and Their Families. |
FDLQI |
| 41 |
2016 |
Quality of life impact of childhood skin conditions measured using the Children's Dermatology Life Quality Index (CDLQI): a meta-analysis. |
QOL |
| 42 |
2016 |
Quality of Life Impairment in Children and Adults with Vitiligo: A Cross-Sectional Study Based on Dermatology-Specific and Disease-Specific Quality of Life Instruments. |
DLQI, QOL, VitiQoL |
| 43 |
2016 |
Translation, cross-cultural adaptation and validation of the Quality of Life Evaluation in Epidermolysis Bullosa instrument in Brazilian Portuguese. |
DDEB, DEB, DLQI, EB, JEB, QoLEB, RDEB, SD |
| 44 |
2016 |
[ASSESSMENT OF QOL BY URTICARIA ACTIVITY SCORE IN PEDIATRIC PATIENTS WITH CHRONIC URTICARIA]. |
DLQI, EAACI, QOL, UAS |
| 45 |
2015 |
An International Multi-center Study on Self-assessed and Family Quality of Life in Children with Atopic Dermatitis. |
AD, DFI, QOL |
| 46 |
2015 |
Anti-TNF agents for paediatric psoriasis. |
CENTRAL, CI, PASI 75, PGA, RCTs, RevMan |
| 47 |
2015 |
Children with atopic dermatitis show clinical improvement after Lactobacillus exposure. |
AD, FDLQI, LF, LP, SCORAD |
| 48 |
2015 |
Correlations among steroid fear, acceptability, usage frequency, quality of life and disease severity in childhood eczema. |
CSs, NESS, QOL |
| 49 |
2015 |
Effect of Automated Online Counseling on Clinical Outcomes and Quality of Life Among Adolescents With Acne Vulgaris: A Randomized Clinical Trial. |
--- |
| 50 |
2015 |
Health-related Quality of Life in Children with Moderate to Severe Atopic Dermatitis. |
AD, HRQoL, IDQOL, QOL, TIS |
| 51 |
2015 |
Quality of life and psychosocial issues are important outcome measures in eczema treatment. |
AE, NESS, SH, TEWL |
| 52 |
2015 |
Quality of life and social isolation in Greek adolescents with primary focal hyperhidrosis treated with botulinum toxin type A: a case series. |
BTX-A, HDSS |
| 53 |
2015 |
The Validity and Reliability of the Thai Version of Children's Dermatology Life Quality Index (CDLQI). |
--- |
| 54 |
2015 |
Time to resolution and effect on quality of life of molluscum contagiosum in children in the UK: a prospective community cohort study. |
MCDTP, WSPCR |
| 55 |
2014 |
Calcipotriol/betamethasone dipropionate ointment in mild-to-moderate paediatric psoriasis: long-term daily clinical practice data in a prospective cohort. |
BSA, PASI, QOL, VAS |
| 56 |
2014 |
Disease-related behavioral patterns and experiences affect quality of life in children and adolescents with vitiligo. |
QOL |
| 57 |
2014 |
Evaluation of the quality of life in adolescents with acne. |
QOL |
| 58 |
2014 |
Good quality of life in former Buruli ulcer patients with small lesions: long-term follow-up of the BURULICO trial. |
DLQI, QOL |
| 59 |
2014 |
Mild eczema affects self-perceived health among pre-adolescent girls. |
--- |
| 60 |
2014 |
Quality of life impairment in children and adolescents with vitiligo. |
BSA, QOL |
| 61 |
2014 |
Quality of life in pediatric patients before and after cosmetic camouflage of visible skin conditions. |
QOL |
| 62 |
2014 |
Specific IgG and IgA of common foods in Chinese children with eczema: friend or foe. |
AD, GAT, NESS, SCORAD, SH, TEWL |
| 63 |
2013 |
Circulating immunoglobulins, leucocytes and complements in childhood-onset atopic eczema. |
NESS |
| 64 |
2013 |
Clinical experience and psychometric properties of the Children's Dermatology Life Quality Index (CDLQI), 1995-2012. |
--- |
| 65 |
2013 |
Dermatological quality of life instruments in children. |
HRQoL |
| 66 |
2013 |
Dermatology life quality index scores in children with vitiligo: comparison with atopic dermatitis and healthy control subjects. |
AD, QOL |
| 67 |
2013 |
Evaluation of the efficacy and safety of a Chinese herbal formula (RCM-106) for atopic dermatitis: study protocol for a randomised, double-blind, placebo-controlled trial in children. |
HREC, PO-SCORAD, RCM-106, SCORAD |
| 68 |
2013 |
Preadolescent moderate acne vulgaris: a randomized trial of the efficacy and safety of topical adapalene-benzoyl peroxides. |
AEs, IGA |
| 69 |
2013 |
The Cardiff Acne Disability Index (CADI): linguistic and cultural validation in Serbian. |
CADI |
| 70 |
2013 |
The Children's Dermatology Life Quality Index (CDLQI): linguistic and cultural validation in Serbian. |
CADI |
| 71 |
2012 |
A comparative study of the impairment of quality of life in Czech children with atopic dermatitis of different age groups and their families. |
AD, DFI, IDQOL |
| 72 |
2012 |
Assessment of the quality of life of pediatric patients with the major chronic childhood skin diseases. |
--- |
| 73 |
2012 |
Health-related quality of life in patients with atopic dermatitis. |
AD, DLQI, EASI, QOL, SF-36 |
| 74 |
2012 |
Impact of photosensitivity disorders on the life quality of children. |
QOL |
| 75 |
2012 |
Italian validation of the Childhood Atopic Dermatitis Impact Scale: a contribution to its clinical application. |
AD, CADIS, DFI, IDQOL, SCORAD |
| 76 |
2012 |
Perception of xeroderma pigmentosum support group members of xeroderma pigmentosum lifestyle impact. |
DLQI, XP |
| 77 |
2012 |
Prospective self-controlled trial of the efficacy and tolerability of a herbal syrup for young children with eczema. |
AD, SCORAD, TCM |
| 78 |
2012 |
Quality of life among schoolchildren with acne: results of a cross-sectional study. |
CADI, HRQoL |
| 79 |
2012 |
Quality of life and disease severity are correlated in patients with atopic dermatitis. |
AD, DLQI, IDQOL, QOL, SCORAD |
| 80 |
2012 |
The influence of treatments in daily clinical practice on the Children's Dermatology Life Quality Index in juvenile psoriasis: a longitudinal study from the Child-CAPTURE patient registry. |
PASI, QOL |
| 81 |
2011 |
A pilot trial of dermoscopy as a rapid assessment tool in pediatric dermatoses. |
AD, EASI, KP |
| 82 |
2011 |
Balneotherapy for atopic dermatitis in children at Comano spa in Trentino, Italy. |
AD, FDIQ, IGA, PSGA, TCS |
| 83 |
2011 |
Costs and cost-effectiveness analysis of treatment in children with eczema by nurse practitioner vs. dermatologist: results of a randomized, controlled trial and a review of international costs. |
ICER, IDQOL, NPs, RCT |
| 84 |
2011 |
Exploring CCL18, eczema severity and atopy. |
AD, PARC, SCORAD |
| 85 |
2011 |
Impact of Avene hydrotherapy on the quality of life of atopic and psoriatic patients. |
DLQI, SF-12 |
| 86 |
2011 |
Influence of childhood scleroderma on physical function and quality of life. |
CHAQ, CQOL, SSc |
| 87 |
2011 |
Patient-reported outcomes in pediatric patients with psoriasis undergoing etanercept treatment: 12-week results from a phase III randomized controlled trial. |
HRQoL |
| 88 |
2011 |
Specific IgE of common foods in Chinese children with eczema. |
AD |
| 89 |
2010 |
A cross-sectional study using the Children's Dermatology Life Quality Index (CDLQI) in childhood psoriasis: negative effect on quality of life and moderate correlation of CDLQI with severity scores. |
IQR, PASI, PGA, QOL |
| 90 |
2010 |
A randomized controlled trial in children with eczema: nurse practitioner vs. dermatologist. |
CI, IDQOL |
| 91 |
2010 |
Development and initial validation of the localized scleroderma skin damage index and physician global assessment of disease damage: a proof-of-concept study. |
DAT, DP, LoSCAT, LS, PGA-D, PtGA-S, SAT |
| 92 |
2010 |
Estimating emollient usage in patients with eczema. |
AE, NESS, SCORAD, SH, TEWL |
| 93 |
2010 |
Quality of life in Swedish children with congenital ichthyosis. |
DFI |
| 94 |
2009 |
Health-related quality of life in children and adolescents with juvenile localized scleroderma. |
AD, HRQoL, JLS |
| 95 |
2009 |
Impact of neurofibromatosis 1 upon quality of life in childhood: a cross-sectional study of 79 cases. |
NF1, QOL |
| 96 |
2009 |
The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress toward development of localized scleroderma outcome measures. |
ER, ICC, LS, N/E, PhysGA-A, PtGA-S, QOL, SA, ST |
| 97 |
2008 |
A pilot study to explore the usefulness of antibody array in childhood atopic dermatitis. |
AD, NESS, SCORAD |
| 98 |
2008 |
Comparison of skin hydration evaluation sites and correlations among skin hydration, transepidermal water loss, SCORAD index, Nottingham Eczema Severity Score, and quality of life in patients with atopic dermatitis. |
AD, NESS, SCORAD, SH, TEWL |
| 99 |
2008 |
Does age or gender influence quality of life in children with atopic dermatitis? |
AD, NESS, QOL, SCORAD |
| 100 |
2008 |
Improvement of pruritus and quality of life of children with atopic dermatitis and their families after joining support groups. |
FDI, QOL |
|
A Search Service for Abbreviation / Long Form
